Neurodegeneration 2013

1,065 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,065
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
28
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Neurodegeneration 2013

  1. 1. Sample & Assay Technologies Molecular Mechanisms of Neurodegeneration Jesse Liang, Ph.D.
  2. 2. Sample & Assay Technologies Neurodegeneration Neurodegeneration is featured by progressive dysfunction and death of cells in selected areas in the nervous system. 1. 2. 3. 4. • • • • Alzheimer’s Disease (AD) Parkinson’s Disease (PD) Huntington’s Disease (HD) Multiple Sclerosis (MS) abnormal protein assemblies (protein misfolding) oxidative stress Late-onset cell death in adulthood inflammation
  3. 3. Sample & Assay Technologies Selected Area of Changes Overview of the anatomical locations and macroscopic and microscopic changes characteristic of the neurodegenerative disorders (The genetic epidemiology of neurodegenerative disease, J Clin Invest. 2005 June 1; 115(6): 1449–1457)
  4. 4. Sample & Assay Technologies Overview of Mutant Genes Causing Neurodegeneration
  5. 5. Sample & Assay Technologies Two Pathways to Clear Up Proteins 1. Ubiquitin – Proteasome • This is the primary route cells use to degrade proteins. • Decreased proteasome activity is observed in neurodegeneration. • Mutation of a deubiquitinating enzyme (ubiquitin carboxylterminal hydrolase, UCHL1) in PD 2. Autophagy – Lysosome • When proteins are poor proteasome substrates.
  6. 6. Sample & Assay Technologies Aging – The Greatest Risk Factor The greatest risk factor for neurodegeneration is aging. Genes that mediate oxidative stress responses and DNA damage repair constitute the largest class of genes upregulated in aging.
  7. 7. Sample & Assay Technologies Aging – Oxidative Stress • The highly abundant mitochondria in brain cells are a major site of generation and action of ROS (reactive oxygen species) / RNS (reactive nitrogen species) since the brain uses 20% of the inspired oxygen and 90% of the consumed oxygen to produce energy. The neuronal cells are thus particularly sensitive to oxidative stress. • Mitochondria are both generators of and targets for reactive species. Mitochondria generate ROS from a number of different redox centers in the respiratory chain and other metabolic pathways. Therefore oxidative stress is inseparably linked to mitochondrial dysfunction. • Mitochondrial turnover is dependent on autophagy (meaning “self-eating”), which declines with age and is frequently dysfunctional in neurodegeneration. mTOR functions as an inhibitor of the initiation step of autophagy. Defining the stages of autophagy and its progress in a tissue or cell is important for understanding its function and regulation.
  8. 8. Sample & Assay Technologies Aging – DNA Repair Mutations in DNA surveillance and DNA repair enzymes are associated with neurodegeneration.
  9. 9. Sample & Assay Technologies The Major Apoptotic Pathways in Neurodegeneration Mark F. Mehler and Solen Gokhan. Trends Neurosci. (2000) 23, 599–605
  10. 10. Sample & Assay Technologies • • • • • Other Signaling Pathways Wnt Notch Akt NFκB CREB The Wnt signaling network interacts with and regulates a number of neurogenic (e.g. Notch), cell adhesion (e.g. cadherins, integrins), cell cycle (Myc, cyclin D1) and viability (e.g. Akt, JNK) pathways that mediate numerous neurodevelopmental processes.
  11. 11. Sample & Assay Technologies Neurodegeneration is a Novel Class of Development Disorders Neurodegenerative diseases may represent fundamental disorders of neurogenesis and neural development.
  12. 12. Sample & Assay Technologies Inflammation in Alzheimer’s Disease There is a remarkable convergence in the mechanisms responsible for the sensing, transduction, and amplification of inflammatory responses that result in the production of neurotoxic mediators. Mechanisms Underlying Inflammation in Neurodegeneration. Cell (2010) 140, 918–934.
  13. 13. Sample & Assay Technologies Inflammation in Parkinson’s Disease
  14. 14. Sample & Assay Technologies Inflammation in Multiple Sclerosis * A Role of the Estrogen Receptor in Suppression of Inflammation http://www.sabiosciences.com/pathwaymagazine/minireview/neuroinflam.php
  15. 15. Sample & Assay Technologies Focused Neuronal Genomics – 5 Technologies 1. mRNA gene expression 2. microRNA expression 3. Methylation screening 4. Mutation detection 5. Gene copy number alteration
  16. 16. Sample & Assay Technologies • • • • • • • • • • • • • • • • • Gene Expression at mRNA Level – PCR Arrays Oxidative stress Unfolded protein response (ER stress) DNA damage Synaptic plasticity Alzheimer’s disease Parkinson’s disease Huntington’s disease Multiple sclerosis Amino acid metabolism Autophagy Neuronal ion channels Neurotransmitters & receptors Neurotrophins Dopamine & serotonin pathway GABA & glutamate Neurogenesis Pain http://www.sabiosciences.com/neuroscience.php
  17. 17. Sample & Assay Technologies PCR Array Introduction 84 pathway-specific genes of interest 5 housekeeping genes Genomic DNA contamination control Reverse transcription controls (RTC) n=3 Positive PCR controls (PPC) n=3
  18. 18. Sample & Assay Technologies microRNA Expression – microRNA PCR Arrays • Neurological development and disease • Apoptosis • Cell development & differentiation • Brain cancers • Serum and plasma miRNAs http://www.sabiosciences.com/mirna_pcr_array.php
  19. 19. Sample & Assay Technologies Gene Methylation Screening – Methylation PCR Arrays • Apoptosis • Wnt signaling • Notch signaling • Mental disorders http://www.sabiosciences.com/dna_methylation_array.php
  20. 20. Sample & Assay Technologies Gene Copy Number Alterations – CNV PCR Arrays • Alzheimer’s disease • Intellectual disability • Glioma • Birth defects • Autism spectrum disorders • Schizophrenia http://www.sabiosciences.com/copynumberarray.php
  21. 21. Sample & Assay Technologies Mutation Detection – Mutation PCR Arrays • PI3K-Akt pathway • Receptor tyrosine kinases (RTKs) • Brain cancer http://www.sabiosciences.com/mutationproductlist.php?tab=arraysbypathway
  22. 22. Sample & Assay Technologies We Also Provide Services – Simply Send Your Samples • RNA extraction • DNA extraction • Illumina chips • All sorts of PCR Arrays http://www.sabiosciences.com/servicecore.php
  23. 23. Sample & Assay Technologies Contact Information Jesse Liang Email: jesse.liang@qiagen.com Technical Support: 1-888-503-3187 Email: support@sabiosciences.com Check Webinar Calendar: http://www.sabiosciences.com/seminarlist.php Regular PCR Arrays: April 4(Thursday) microRNA PCR Arrays: March 15/22/29 (Fridays) Methylation PCR Arrays: March 28 (Thursday) Mutation PCR Arrays: April 9 (Tuesday) Copy Number Variation PCR Arrays: April 18 (Thursday)

×